22 results on '"NNA1"'
Search Results
2. The Childhood-Onset Neurodegeneration with Cerebellar Atrophy (CONDCA) Disease Caused by AGTPBP1 Gene Mutations: The Purkinje Cell Degeneration Mouse as an Animal Model for the Study of this Human Disease
- Author
-
Fernando C. Baltanás, María T. Berciano, Eugenio Santos, and Miguel Lafarga
- Subjects
AGTPBP1 ,CCP1 ,CONDCA ,neurodegeneration ,NNA1 ,pcd ,Biology (General) ,QH301-705.5 - Abstract
Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration (pcd) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA.
- Published
- 2021
- Full Text
- View/download PDF
3. Alteration of Neural Stem Cell Functions in Ataxia and Male Sterility Mice: A Possible Role of β-Tubulin Glutamylation in Neurodegeneration
- Author
-
Abdullah Md. Sheikh, Shozo Yano, Shatera Tabassum, Koji Omura, Asuka Araki, Shingo Mitaki, Yoshie Ito, Shuai Huang, and Atsushi Nagai
- Subjects
AMS mouse ,NSC ,deglutamylation ,β-tubulin ,MAP2 ,NNA1 ,Cytology ,QH573-671 - Abstract
Ataxia and Male Sterility (AMS) is a mutant mouse strain that contains a missense mutation in the coding region of Nna1, a gene that encodes a deglutamylase. AMS mice exhibit early cerebellar Purkinje cell degeneration and an ataxic phenotype in an autosomal recessive manner. To understand the underlying mechanism, we generated neuronal stem cell (NSC) lines from wild-type (NMW7), Nna1 mutation heterozygous (NME), and Nna1 mutation homozygous (NMO1) mouse brains. The NNA1 levels were decreased, and the glutamylated tubulin levels were increased in NMO1 cultures as well as in the cerebellum of AMS mice at both 15 and 30 days of age. However, total β-tubulin protein levels were not altered in the AMS cerebellum. In NMO1 neurosphere cultures, β-tubulin protein levels were increased without changes at the transcriptional level. NMO1 grew faster than other NSC lines, and some of the neurospheres were attached to the plate after 3 days. Immunostaining revealed that SOX2 and nestin levels were decreased in NMO1 neurospheres and that the neuronal differentiation potentials were reduced in NMO1 cells compared to NME or NMW7 cells. These results demonstrate that the AMS mutation decreased the NNA1 levels and increased glutamylation in the cerebellum of AMS mice. The observed changes in glutamylation might alter NSC properties and the neuron maturation process, leading to Purkinje cell death in AMS mice.
- Published
- 2021
- Full Text
- View/download PDF
4. Deletion of exons encoding carboxypeptidase domain of Nna1 results in Purkinje cell degeneration (pcd) phenotype.
- Author
-
Zhou, Li, Hossain, M. Ibrahim, Yamazaki, Maya, Abe, Manabu, Natsume, Rie, Konno, Kohtaro, Kageyama, Shun, Komatsu, Masaaki, Watanabe, Masahiko, Sakimura, Kenji, and Takebayashi, Hirohide
- Subjects
- *
CARBOXYPEPTIDASES , *KNOCKOUT mice , *PURKINJE cells , *CEREBELLAR ataxia , *PHOTORECEPTORS , *MESSENGER RNA - Abstract
Purkinje cell degeneration (pcd) was first identified in a spontaneous mouse mutant showing cerebellar ataxia. In addition to cerebellar Purkinje cells (PCs), retinal photoreceptors, mitral cells in the olfactory bulb, and a discrete subpopulation of thalamic neurons also degenerate in the mutant brains. The gene responsible for the pcd mutant is Nna1, also known as ATP/GTP binding protein 1 or cytosolic carboxypeptidase‐like 1, which encodes a zinc carboxypeptidase protein. To investigate pathogenesis of the pcd mutation in detail, we generated a conditional Nna1 allele targeting the carboxypeptidase domain at C‐terminus. After Cre recombination and heterozygous crossing, we generated Nna1 knockout (KO) mice and found that the Nna1 KO mice began to show cerebellar ataxia at postnatal day 20 (P20). Most PCs degenerated until 4‐week‐old, except lobule X. Activated microglia and astrocytes were also observed in the Nna1 KO cerebellum. In the mutant brain, the Nna1 mRNA level was dramatically reduced, suggesting that nonsense‐mediated mRNA decay occurs in it. Since the Nna1 protein acts as a de‐glutamatase on the C‐terminus of α‐tubulin and β‐tubulin, increased polyglutamylated tubulin was detected in the Nna1 KO cerebellum. In addition, the endoplasmic reticulum stress marker, C/EBP homologous protein (CHOP), was up‐regulated in the mutant PCs. We report the generation of a functional Nna1 conditional allele and possible mechanisms of PC death in the Nna1 KO in the cerebellum. Open Practices: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. A novel Nna1 flox allele was generated, which is causative gene for Purkinje cell degeneration (pcd) mutant mice. The Nna1 null mice showed pcd phenotype, as well as neurodegeneration in the retina and olfactory bulb and defect in spermatogenesis. In addition, Calbindin D‐28k immunostaining at 4‐week‐old showed that Purkinje cells of the lobule X are relatively resistant to neuronal cell death. This Nna1 flox allele is useful for analyses of Nna1 functions in multiple organs (Scale bars: 500 μm). Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/ [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. The Childhood-Onset Neurodegeneration with Cerebellar Atrophy (CONDCA) Disease Caused by AGTPBP1 Gene Mutations: The Purkinje Cell Degeneration Mouse as an Animal Model for the Study of this Human Disease
- Author
-
Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica, Fondo Europeo de Desarrollo Regional. Universidad de Salamanca SA264P18-UIC076, Instituto de Salud Carlos III (CIBERNED) CB/05/0037, Instituto de Salud Carlos III (CIBERONC) CB16/12/00352, Gobierno regional de Castilla y León, Fundación Samuel-Solorzano Barruso. Universidad de Salamanca FS/32-2020, Instituto de Investigación Valdecilla, Calvo Baltanás, Fernando, Berciano, María T., Santos, Eugenio, Lafarga, Miguel, Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica, Fondo Europeo de Desarrollo Regional. Universidad de Salamanca SA264P18-UIC076, Instituto de Salud Carlos III (CIBERNED) CB/05/0037, Instituto de Salud Carlos III (CIBERONC) CB16/12/00352, Gobierno regional de Castilla y León, Fundación Samuel-Solorzano Barruso. Universidad de Salamanca FS/32-2020, Instituto de Investigación Valdecilla, Calvo Baltanás, Fernando, Berciano, María T., Santos, Eugenio, and Lafarga, Miguel
- Abstract
Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration (pcd) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA.
- Published
- 2021
6. The childhood-onset neurodegeneration with cerebellar atrophy (Condca) disease caused by agtpbp1 gene mutations: The purkinje cell degeneration mouse as an animal model for the study of this human disease
- Author
-
Instituto de Salud Carlos III, Instituto de Investigación Marqués de Valdecilla, Junta de Castilla y León, Universidad de Salamanca, Fundación Memoria de D. Samuel Solorzano Barruso, Baltanás, Fernando C., Berciano, María T., Santos de Dios, Eugenio, Lafarga, Miguel, Instituto de Salud Carlos III, Instituto de Investigación Marqués de Valdecilla, Junta de Castilla y León, Universidad de Salamanca, Fundación Memoria de D. Samuel Solorzano Barruso, Baltanás, Fernando C., Berciano, María T., Santos de Dios, Eugenio, and Lafarga, Miguel
- Abstract
Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration (pcd) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA.
- Published
- 2021
7. The childhood-onset neurodegeneration with cerebellar atrophy (Condca) disease caused by agtpbp1 gene mutations: The purkinje cell degeneration mouse as an animal model for the study of this human disease
- Author
-
Baltanás, Fernando C., Berciano, María T., Santos de Dios, Eugenio, Lafarga, Miguel, Instituto de Salud Carlos III, Instituto de Investigación Marqués de Valdecilla, Junta de Castilla y León, Universidad de Salamanca, and Fundación Memoria de D. Samuel Solorzano Barruso
- Subjects
CONDCA ,CCP1 ,Neurodegeneration ,AGTPBP1 ,Pcd ,NNA1 - Abstract
© 2021 by the authors. Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration (pcd) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA. This work was supported by funding received by the Institute of Health Carlos III (CIBERONC, CB16/12/00352 and CIBERNED, CB/05/0037), the Valdecilla Research Institute (IDIVAL, Santander Spain), the Regional Government of Castile and Leon, funds received by the European Regional Development Fund (SA264P18-UIC076; University of Salamanca, Spain) and the Samuel-Solórzano Barruso Foundation (FS/32-2020, University of Salamanca, Spain)
- Published
- 2021
8. The childhood-onset neurodegeneration with cerebellar atrophy (CONDCA) disease caused by AGTPBP1 gene mutations: the Purkinje cell degeneration mouse as an animal model for the study of this human disease
- Author
-
Eugenio Santos, Fernando C. Baltanás, Maria T. Berciano, Miguel Lafarga, Universidad de Cantabria, Instituto de Salud Carlos III, Instituto de Investigación Marqués de Valdecilla, Junta de Castilla y León, Universidad de Salamanca, Fundación Memoria de D. Samuel Solorzano Barruso, Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica, Fondo Europeo de Desarrollo Regional. Universidad de Salamanca SA264P18-UIC076, Instituto de Salud Carlos III (CIBERNED) CB/05/0037, Instituto de Salud Carlos III (CIBERONC) CB16/12/00352, Gobierno regional de Castilla y León, Fundación Samuel-Solorzano Barruso. Universidad de Salamanca FS/32-2020, and Instituto de Investigación Valdecilla
- Subjects
Ataxia ,QH301-705.5 ,Purkinje cell ,Medicine (miscellaneous) ,Review ,Gene mutation ,pcd ,General Biochemistry, Genetics and Molecular Biology ,medicine ,Cognitive decline ,Biology (General) ,Neurodegeneration ,CONDCA ,Cerebellar ataxia ,business.industry ,neurodegeneration ,medicine.disease ,AGTPBP1 ,Pcd ,Hypotonia ,NNA1 ,medicine.anatomical_structure ,Cerebellar atrophy ,medicine.symptom ,CCP1 ,business ,Neuroscience - Abstract
© 2021 by the authors., Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration (pcd) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA., This work was supported by funding received by the Institute of Health Carlos III (CIBERONC, CB16/12/00352 and CIBERNED, CB/05/0037), the Valdecilla Research Institute (IDIVAL, Santander Spain), the Regional Government of Castile and Leon, funds received by the European Regional Development Fund (SA264P18-UIC076; University of Salamanca, Spain) and the Samuel-Solórzano Barruso Foundation (FS/32-2020, University of Salamanca, Spain)
- Published
- 2021
9. Bioinformatics Data Mining Approach Suggests Coexpression of AGTPBP1 with an ALS-linked Gene C9orf72.
- Author
-
Shouta Kitano, Yoshihiro Kino, Yoji Yamamoto, Mika Takitani, Junko Miyoshi, Tsuyoshi Ishida, Yuko Saito, Kunimasa Arima, and Jun-ichi Satoh
- Published
- 2015
- Full Text
- View/download PDF
10. Alteration of Neural Stem Cell Functions in Ataxia and Male Sterility Mice: A Possible Role of β-Tubulin Glutamylation in Neurodegeneration
- Author
-
Atsushi Nagai, Shatera Tabassum, Koji Omura, Shuai Huang, Asuka Araki, Shozo Yano, Abdullah Md. Sheikh, Shingo Mitaki, and Yoshie Ito
- Subjects
0301 basic medicine ,Male ,Cerebellum ,AMS mouse ,Ataxia ,Glutamine ,Purkinje cell ,Cerebellar Purkinje cell ,MAP2 ,Biology ,Article ,03 medical and health sciences ,Mice ,NSC ,0302 clinical medicine ,Neural Stem Cells ,Tubulin ,Neurosphere ,medicine ,NAD(P)H Dehydrogenase (Quinone) ,Animals ,lcsh:QH301-705.5 ,deglutamylation ,Infertility, Male ,General Medicine ,Nestin ,Neural stem cell ,Mice, Mutant Strains ,Cell biology ,NNA1 ,030104 developmental biology ,medicine.anatomical_structure ,lcsh:Biology (General) ,nervous system ,Neuron maturation ,Heredodegenerative Disorders, Nervous System ,Female ,β-tubulin ,medicine.symptom ,030217 neurology & neurosurgery - Abstract
Ataxia and Male Sterility (AMS) is a mutant mouse strain that contains a missense mutation in the coding region of Nna1, a gene that encodes a deglutamylase. AMS mice exhibit early cerebellar Purkinje cell degeneration and an ataxic phenotype in an autosomal recessive manner. To understand the underlying mechanism, we generated neuronal stem cell (NSC) lines from wild-type (NMW7), Nna1 mutation heterozygous (NME), and Nna1 mutation homozygous (NMO1) mouse brains. The NNA1 levels were decreased, and the glutamylated tubulin levels were increased in NMO1 cultures as well as in the cerebellum of AMS mice at both 15 and 30 days of age. However, total &beta, tubulin protein levels were not altered in the AMS cerebellum. In NMO1 neurosphere cultures, &beta, tubulin protein levels were increased without changes at the transcriptional level. NMO1 grew faster than other NSC lines, and some of the neurospheres were attached to the plate after 3 days. Immunostaining revealed that SOX2 and nestin levels were decreased in NMO1 neurospheres and that the neuronal differentiation potentials were reduced in NMO1 cells compared to NME or NMW7 cells. These results demonstrate that the AMS mutation decreased the NNA1 levels and increased glutamylation in the cerebellum of AMS mice. The observed changes in glutamylation might alter NSC properties and the neuron maturation process, leading to Purkinje cell death in AMS mice.
- Published
- 2020
11. Quantification of Individual Gases/Odors Using Dynamic Responses of Gas Sensor Array With ASM Feature Technique.
- Author
-
Sharma, Sunny, Mishra, V. N., Dwivedi, R., and Das, R. R.
- Abstract
This paper is a continuation of our previous work in which a new feature technique called average slope multiplication (ASM) was proposed to classify the individual gases/odors using dynamic responses of sensor array. The ASM method is used to quantify the individual gases/odors in this paper. Back propagation algorithm based two different neural network architectures (NNAs) called NNA1 and NNA2 are used to assess the ability of the ASM technique for quantification. The proposed method thus utilizes the newly developed feature method in the first stage and the specially designed neural quantifiers in the next subsequent stages. The ability of the proposed method has been insured by applying it on the published dynamic responses of the thick film gas sensor array. When the raw data were directly fed to the neural quantifiers, the results were 69% and 63% accurate for NNA1 and NNA2, respectively. The principal component analysis preprocessed version of raw data provided 74% and 67% quantification accuracy with the aforementioned architectures respectively. The performances of the ASM data were found to be 100% using both the network architecture without need of further preprocessing, with relatively less number of epochs and without any hidden layer. Thus, the proposed method can be utilized in electronic nose for classification/quantification purpose. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
12. Abnormal sperm development in pcd -/- mice: the importance of Agtpbp1 in spermatogenesis.
- Author
-
Kim, Nameun, Xiao, Rui, Choi, Hojun, Jo, Haiin, Kim, Jin-Hoi, Uhm, Sang-Jun, and Park, Chankyu
- Abstract
Homozygous Purkinje cell degeneration ( pcd) mutant males exhibit abnormal sperm development. Microscopic examination of the testes from pcd -/- mice at postnatal days 12, 15, 18 and 60 revealed histological differences, in comparison to wild-type mice, which were evident by day 18. Greatly reduced numbers of spermatocytes and spermatids were found in the adult testes, and apoptotic cells were identified among the differentiating germ cells after day 15. Our immunohistological analysis using an antihuman AGTPBP1 antibody showed that AGTPBP1 was expressed in spermatogenic cells between late stage primary spermatocytes and round spermatids. A global gene expression analysis from the testes of pcd -/- mice showed that expression of cyclin B3 and de-ubiquitinating enzymes USP2 and USP9y was altered by >1.5-fold compared to the expression levels in the wild-type. Our results suggest that the pcd mutant mice have defects in spermatogenesis that begin with the pachytene spermatocyte stage and continue through subsequent stages. Thus, Agtpbp1, the gene responsible for the pcd phenotype, plays an important role in spermatogenesis and is important for survival of germ cells at spermatocytes stage onward. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. The Ataxic Syrian Hamster: An Animal Model Homologous to the pcd Mutant Mouse?
- Author
-
Akita, Kenji and Arai, Shigeyuki
- Subjects
- *
CEREBELLAR ataxia , *FRIEDREICH'S ataxia , *CEREBELLUM , *PURKINJE cells , *GENE expression - Abstract
A spontaneous model of cerebellar ataxia in the Syrian hamster is described. Breeding data indicate that the condition is hereditary and that the mode of inheritance is autosomal recessive. Homozygotes are smaller in size than the wild-type but have a normal appearance. Mutants show a moderate ataxia beginning at 7 weeks of age. Although affected adults exhibit significant atrophy in the cerebellum, other parts of the brain appear relatively normal by light microscopy. Mutants lose almost all Purkinje cells by 18 months of age and exhibit a moderate reduction in granule cell density, probably as a consequence of the primary loss of Purkinje cells. In the homozygous hamster brain, Nna1 expression is suppressed, similar to that previously observed in Purkinje cell degeneration ( pcd) mutant mice. A phenotypic comparison of ataxic hamsters with the pcd mutant mice suggests that the influence of the causal allele in ataxic hamsters is considerably milder than most of the alleles found in the mutant mice. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
14. The Purkinje cell degeneration (pcd) mouse: An unexpected molecular link between neuronal degeneration and regeneration
- Author
-
Wang, Taiyu and Morgan, James I.
- Subjects
- *
PURKINJE cells , *ANIMAL mutation , *LABORATORY mice , *PHENOTYPES - Abstract
Abstract: The spontaneous autosomal recessive mouse mutation, Purkinje cell degeneration (pcd), was first identified through its ataxic behavior. Since its discovery in the 1970s, the strain has undergone extensive investigation, although another quarter century elapsed until the mutant gene (agtpbp1 a.k.a. Nna1) underlying the pcd phenotype was identified. As Nna1 was initially discovered as a gene induced in motor neurons following axotomy the finding that its loss leads to selective neuronal degeneration points to a novel and unexpected common molecular mechanism contributing to the apparently opposing processes of degeneration and regeneration. The elucidation of this mechanism may of course have significant implications for an array of neurological disorders. Here we will first review the principle features of the pcd phenotype and then discuss the functional implications of more recent findings emanating from the characterization of Nna1, the protein that is lost in pcd. We also provide new data on the genetic dissection of the cell death pathways operative in pcd 3J mice, proving that granule cell death and Purkinje cell death in these mice have distinct molecular bases. We also provide new information on the structure of mouse Nna1 as well as Nna1 protein levels in pcd 3J mice. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
15. Tubulin polyglutamylation, a regulator of microtubule functions, can cause neurodegeneration.
- Author
-
Bodakuntla, Satish, Janke, Carsten, and Magiera, Maria M.
- Subjects
- *
TUBULINS , *POST-translational modification , *NEURODEGENERATION , *DISEASE progression , *AXONAL transport - Abstract
• Microtubules are involved in a large variety of neurodegenerative disorders. • Polyglutamylation is a posttranslational modification of microtubules in neurons. • Polyglutamylation regulates functions and properties of microtubules. • Hyperglutamylation is causative for early-onset neurodegeneration in mice and human. • Perturbed polyglutamylation might be widely involved in neurodegeneration. Neurodegenerative diseases lead to a progressive demise of neuronal functions that ultimately results in neuronal death. Besides a large variety of molecular pathways that have been linked to the degeneration of neurons, dysfunctions of the microtubule cytoskeleton are common features of many human neurodegenerative disorders. Yet, it is unclear whether microtubule dysfunctions are causative, or mere bystanders in the disease progression. A so-far little explored regulatory mechanism of the microtubule cytoskeleton, the posttranslational modifications of tubulin, emerge as candidate mechanisms involved in neuronal dysfunction, and thus, degeneration. Here we review the role of tubulin polyglutamylation, a prominent modification of neuronal microtubules. We discuss the current understanding of how polyglutamylation controls microtubule functions in healthy neurons, and how deregulation of this modification leads to neurodegeneration in mice and humans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. The Childhood-Onset Neurodegeneration with Cerebellar Atrophy (CONDCA) Disease Caused by AGTPBP1 Gene Mutations: The Purkinje Cell Degeneration Mouse as an Animal Model for the Study of this Human Disease.
- Author
-
Baltanás FC, Berciano MT, Santos E, and Lafarga M
- Abstract
Recent reports have identified rare, biallelic damaging variants of the AGTPBP1 gene that cause a novel and documented human disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), linking loss of function of the AGTPBP1 protein to human neurodegenerative diseases. CONDCA patients exhibit progressive cognitive decline, ataxia, hypotonia or muscle weakness among other clinical features that may be fatal. Loss of AGTPBP1 in humans recapitulates the neurodegenerative course reported in a well-characterised murine animal model harbouring loss-of-function mutations in the AGTPBP1 gene. In particular, in the Purkinje cell degeneration ( pcd ) mouse model, mutations in AGTPBP1 lead to early cerebellar ataxia, which correlates with the massive loss of cerebellar Purkinje cells. In addition, neurodegeneration in the olfactory bulb, retina, thalamus and spinal cord were also reported. In addition to neurodegeneration, pcd mice show behavioural deficits such as cognitive decline. Here, we provide an overview of what is currently known about the structure and functional role of AGTPBP1 and discuss the various alterations in AGTPBP1 that cause neurodegeneration in the pcd mutant mouse and humans with CONDCA. The sequence of neuropathological events that occur in pcd mice and the mechanisms governing these neurodegenerative processes are also reported. Finally, we describe the therapeutic strategies that were applied in pcd mice and focus on the potential usefulness of pcd mice as a promising model for the development of new therapeutic strategies for clinical trials in humans, which may offer potential beneficial options for patients with AGTPBP1 mutation-related CONDCA.
- Published
- 2021
- Full Text
- View/download PDF
17. Alteration of Neural Stem Cell Functions in Ataxia and Male Sterility Mice: A Possible Role of β-Tubulin Glutamylation in Neurodegeneration.
- Author
-
Sheikh, Abdullah Md., Yano, Shozo, Tabassum, Shatera, Omura, Koji, Araki, Asuka, Mitaki, Shingo, Ito, Yoshie, Huang, Shuai, and Nagai, Atsushi
- Subjects
- *
NEURAL stem cells , *MALE sterility in plants , *CELL physiology , *PURKINJE cells , *CELL death , *ATAXIA - Abstract
Ataxia and Male Sterility (AMS) is a mutant mouse strain that contains a missense mutation in the coding region of Nna1, a gene that encodes a deglutamylase. AMS mice exhibit early cerebellar Purkinje cell degeneration and an ataxic phenotype in an autosomal recessive manner. To understand the underlying mechanism, we generated neuronal stem cell (NSC) lines from wild-type (NMW7), Nna1 mutation heterozygous (NME), and Nna1 mutation homozygous (NMO1) mouse brains. The NNA1 levels were decreased, and the glutamylated tubulin levels were increased in NMO1 cultures as well as in the cerebellum of AMS mice at both 15 and 30 days of age. However, total β-tubulin protein levels were not altered in the AMS cerebellum. In NMO1 neurosphere cultures, β-tubulin protein levels were increased without changes at the transcriptional level. NMO1 grew faster than other NSC lines, and some of the neurospheres were attached to the plate after 3 days. Immunostaining revealed that SOX2 and nestin levels were decreased in NMO1 neurospheres and that the neuronal differentiation potentials were reduced in NMO1 cells compared to NME or NMW7 cells. These results demonstrate that the AMS mutation decreased the NNA1 levels and increased glutamylation in the cerebellum of AMS mice. The observed changes in glutamylation might alter NSC properties and the neuron maturation process, leading to Purkinje cell death in AMS mice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Differential glial activation during the degeneration of Purkinje cells and mitral cells in the PCD mutant mice
- Author
-
José R. Alonso, Carmela Gómez, Eduardo Weruaga, Maria T. Berciano, Fernando C. Baltanás, Miguel Lafarga, Jorge Valero, David Díaz, Fundación Memoria de D. Samuel Solorzano Barruso, Junta de Castilla y León, Instituto de Investigación Marqués de Valdecilla, Ministerio de Ciencia y Tecnología (España), and Instituto de Salud Carlos III
- Subjects
Male ,Cerebellum ,Purkinje cell ,Gene mutation ,Mice ,Purkinje Cells ,Olfactory bulb ,Gliosis ,Oligonucleotide Array Sequence Analysis ,Cell Death ,Microfilament Proteins ,Neurodegeneration ,Age Factors ,Gene Expression Regulation, Developmental ,Olfactory Bulb ,Serine-Type D-Ala-D-Ala Carboxypeptidase ,Cell biology ,medicine.anatomical_structure ,Neurology ,Microglia ,medicine.symptom ,nna1 ,Astrocyte ,Neuroglia ,Mice, Transgenic ,Nerve Tissue Proteins ,Biology ,Cellular and Molecular Neuroscience ,Microscopy, Electron, Transmission ,GTP-Binding Proteins ,Glial Fibrillary Acidic Protein ,In Situ Nick-End Labeling ,medicine ,Animals ,RNA, Messenger ,Cell Proliferation ,Gene Expression Profiling ,Calcium-Binding Proteins ,medicine.disease ,Oligodendrocyte ,Mice, Inbred C57BL ,Purkinje cell degeneration ,Animals, Newborn ,Bromodeoxyuridine ,nervous system ,Mutation ,Nerve Degeneration ,Neuroscience - Abstract
Purkinje Cell Degeneration (PCD) mice harbor a nna1 gene mutation which leads to an early and rapid degeneration of Purkinje cells (PC) between the third and fourth week of age. This mutation also underlies the death of mitral cells (MC) in the olfactory bulb (OB), but this process is slower and longer than in PC. No clear interpretations supporting the marked differences in these neurodegenerative processes exist. Growing evidence suggests that either beneficial or detrimental effects of gliosis in damaged regions would underlie these divergences. Here, we examined the gliosis occurring during PC and MC death in the PCD mouse. Our results demonstrated different glial reactions in both affected regions. PC disappearance stimulated a severe gliosis characterized by strong morphological changes, enhanced glial proliferation, as well as the release of pro-inflammatory mediators. By contrast, MC degeneration seems to promote a more attenuated glial response in the PCD OB compared with that of the cerebellum. Strikingly, cerebellar oligodendrocytes died by apoptosis in the PCD, whereas bulbar ones were not affected. Interestingly, the level of nna1 mRNA under normal conditions was higher in the cerebellum than in the OB, probably related to a faster neurodegeneration and stronger glial reaction in its absence. The glial responses may thus influence the neurodegenerative course in the cerebellum and OB of the mutant mouse brain, providing harmful and beneficial microenvironments, respectively., Grant sponsor: ‘‘Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Instituto de Salud Carlos III’’; Grant number: CB06/05/0037; Grant sponsor: Ministerio de Ciencia y Tecnología; Grant numbers: BFU2010-18284, BFU2011-23983; Grant sponsors: ‘‘Instituto de Formación e Investigación Marqués de Valdecilla’’ (IFIMAV), Junta de Castilla y León, Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León y Fundación Memoria D. Samuel Solórzano-Barruso, Spain.
- Published
- 2012
- Full Text
- View/download PDF
19. A Family of Protein-Deglutamylating Enzymes Associated with Neurodegeneration
- Author
-
Carsten Janke, Jean-Christophe Deloulme, Annie Andrieux, Max Holzer, Christophe Bosc, Montserrat Bosch Grau, Leticia Peris, Nicole Bec, Nicholas D. Gold, Solange Desagher, Benjamin Lacroix, Christian Larroque, Krzysztof Rogowski, Juliette van Dijk, Marie-Jo Moutin, Anouk Bosson, Maria M. Magiera, Centre de recherches de biochimie macromoléculaire ( CRBM ), Université Montpellier 1 ( UM1 ) -Université Montpellier 2 - Sciences et Techniques ( UM2 ) -IFR122-Centre National de la Recherche Scientifique ( CNRS ), Grenoble Institut des Neurosciences ( GIN ), Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut de recherche en cancérologie de Montpellier ( IRCM ), Université Montpellier 1 ( UM1 ) -CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Institut de Génétique Moléculaire de Montpellier ( IGMM ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Paul-Flechsig-Institute of Brain Research, University of Leipzig, This work was supported by the CNRS, the Universities Montpellier 2 and 1, the Institut Curie, the Association pour la Recherche sur le Cancer (ARC) award 3140 to CJ and 4892 and 7927 to AA, the French National Research Agency (ANR) awards 05-JCJC-0035 and 08- JCJC-0007 to CJ, and 'TyrTips' to AA, the Fondation pour la Recherche Médicale (FRM) research grant DEQ20081213977, the HFSP program grant RGP 23/2008 and the EMBO Young Investigator Program grant to CJ, the La Ligue contre le cancer research grant R07Job to AA and the Alzheimer Forschung Initiative project 06825 to MH. BL was supported by a fellowship from the La Ligue contre le Cancer, and the EMBO short-term fellowship ASTF 157-2007. KR received two postdoctoral fellowships from the La Ligue contre le Cancer and the EMBO long-term fellowship ALTF 546-2006, ANR-05-JCJC-0035,Pgases,The polyglutamylase enzyme family: which enzyme is doing what? ( 2005 ), Dubois, Frederic, Jeunes chercheuses et jeunes chercheurs - The polyglutamylase enzyme family: which enzyme is doing what? - - Pgases2005 - ANR-05-JCJC-0035 - JCJC - VALID, Centre de recherche en Biologie Cellulaire (CRBM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Grenoble Institut des Neurosciences (GIN), Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de Génétique Moléculaire de Montpellier (IGMM), Universität Leipzig [Leipzig], ANR-05-JCJC-0035,Pgases,The polyglutamylase enzyme family: which enzyme is doing what?(2005), Université Montpellier 2 - Sciences et Techniques (UM2)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 1 (UM1), and Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
- Subjects
HUMDISEASE ,Carboxypeptidases ,Protein deglutamylation ,Mice ,0302 clinical medicine ,Tubulin ,Cerebellum ,Polyglutamylation ,deglutamylation ,chemistry.chemical_classification ,0303 health sciences ,Mice, Inbred BALB C ,biology ,polyglutamylase ,neurodegeneration ,Olfactory Bulb ,Serine-Type D-Ala-D-Ala Carboxypeptidase ,Nna1 ,Biochemistry ,Polyglutamic Acid ,Myosin light-chain kinase ,Cell Survival ,Molecular Sequence Data ,General Biochemistry, Genetics and Molecular Biology ,MOLNEURO ,polyglutamylation ,Cell Line ,microtubules ,03 medical and health sciences ,Microtubule ,GTP-Binding Proteins ,Detyrosination ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,cytosolic carboxy peptidase ,Animals ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Amino Acid Sequence ,pcd mouse ,[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,030304 developmental biology ,Polyglutamate ,CCP ,Biochemistry, Genetics and Molecular Biology(all) ,TTLL ,Enzyme ,chemistry ,Nerve Degeneration ,biology.protein ,CELLBIO ,Sequence Alignment ,030217 neurology & neurosurgery - Abstract
International audience; Polyglutamylation is a posttranslational modification that generates glutamate side chains on tubulins and other proteins. Although this modification has been shown to be reversible, little is known about the enzymes catalyzing deglutamylation. Here we describe the enzymatic mechanism of protein deglutamylation by members of the cytosolic carboxypeptidase (CCP) family. Three enzymes (CCP1, CCP4, and CCP6) catalyze the shortening of polyglutamate chains and a fourth (CCP5) specifically removes the branching point glutamates. In addition, CCP1, CCP4, and CCP6 also remove gene-encoded glutamates from the carboxyl termini of proteins. Accordingly, we show that these enzymes convert detyrosinated tubulin into Δ2-tubulin and also modify other substrates, including myosin light chain kinase 1. We further analyze Purkinje cell degeneration (pcd) mice that lack functional CCP1 and show that microtubule hyperglutamylation is directly linked to neurodegeneration. Taken together, our results reveal that controlling the length of the polyglutamate side chains on tubulin is critical for neuronal survival.
- Published
- 2010
- Full Text
- View/download PDF
20. Differential glial activation during the degeneration of Purkinje cells and mitral cells in the PCD mutant mice
- Author
-
Fundación Memoria de D. Samuel Solorzano Barruso, Junta de Castilla y León, Instituto de Investigación Marqués de Valdecilla, Ministerio de Ciencia y Tecnología (España), Instituto de Salud Carlos III, Baltanás, Fernando C., Berciano, María T., Valero, Jorge, Gómez, Carmela, Díaz Viñolas, David, Alonso, José R., Lafarga, Miguel, Weruaga, Eduardo, Fundación Memoria de D. Samuel Solorzano Barruso, Junta de Castilla y León, Instituto de Investigación Marqués de Valdecilla, Ministerio de Ciencia y Tecnología (España), Instituto de Salud Carlos III, Baltanás, Fernando C., Berciano, María T., Valero, Jorge, Gómez, Carmela, Díaz Viñolas, David, Alonso, José R., Lafarga, Miguel, and Weruaga, Eduardo
- Abstract
Purkinje Cell Degeneration (PCD) mice harbor a nna1 gene mutation which leads to an early and rapid degeneration of Purkinje cells (PC) between the third and fourth week of age. This mutation also underlies the death of mitral cells (MC) in the olfactory bulb (OB), but this process is slower and longer than in PC. No clear interpretations supporting the marked differences in these neurodegenerative processes exist. Growing evidence suggests that either beneficial or detrimental effects of gliosis in damaged regions would underlie these divergences. Here, we examined the gliosis occurring during PC and MC death in the PCD mouse. Our results demonstrated different glial reactions in both affected regions. PC disappearance stimulated a severe gliosis characterized by strong morphological changes, enhanced glial proliferation, as well as the release of pro-inflammatory mediators. By contrast, MC degeneration seems to promote a more attenuated glial response in the PCD OB compared with that of the cerebellum. Strikingly, cerebellar oligodendrocytes died by apoptosis in the PCD, whereas bulbar ones were not affected. Interestingly, the level of nna1 mRNA under normal conditions was higher in the cerebellum than in the OB, probably related to a faster neurodegeneration and stronger glial reaction in its absence. The glial responses may thus influence the neurodegenerative course in the cerebellum and OB of the mutant mouse brain, providing harmful and beneficial microenvironments, respectively.
- Published
- 2013
21. Bioinformatics Data Mining Approach Suggests Coexpression of AGTPBP1 with an ALS-linked Gene C9orf72
- Author
-
Yuko Saito, Junko Miyoshi, Jun-ichi Satoh, Yoshihiro Kino, Shouta Kitano, Mika Takitani, Kunimasa Arima, Yoji Yamamoto, and Tsuyoshi Ishida
- Subjects
amyotrophic lateral sclerosis ,Chromosome 9 ,Bioinformatics ,medicine.disease_cause ,frontotemporal dementia ,lcsh:RC346-429 ,COXPRESdb ,C9orf72 ,Medicine ,Amyotrophic lateral sclerosis ,Gene ,lcsh:Neurology. Diseases of the nervous system ,Original Research ,Mutation ,business.industry ,coexpression ,bioinformatics ,Transfection ,AGTPBP1 ,medicine.disease ,NNA1 ,Open reading frame ,CCP1 ,business ,Haploinsufficiency - Abstract
Background Expanded GGGGCC hexanucleotide repeats located in the noncoding region of the chromosome 9 open reading frame 72 ( C9orf72) gene represent the most common genetic abnormality for familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Formation of nuclear RNA foci, accumulation of repeat-associated non-ATG-translated dipeptide-repeat proteins, and haploinsufficiency of C9orf72 are proposed for pathological mechanisms of C9ALS/FTD. However, at present, the physiological function of C9orf72 remains largely unknown. Methods By searching on a bioinformatics database named COXPRESdb composed of the comprehensive gene coexpression data, we studied potential C9orf72 interactors. Results We identified the ATP/GTP binding protein 1 ( AGTPBP1) gene alternatively named NNA1 encoding a cytosolic carboxypeptidase whose mutation is causative of the degeneration of Purkinje cells and motor neurons as the most significant gene coexpressed with C9orf72. We verified coexpression and interaction of AGTPBP1 and C9orf72 in transfected cells by immunoprecipitation and in neurons of the human brain by double-labeling immunohistochemistry. Furthermore, we found a positive correlation between AGTPBP1 and C9orf72 mRNA expression levels in the set of 21 human brains examined. Conclusions These results suggest that AGTPBP1 serves as a C9orf72 interacting partner that plays a role in the regulation of neuronal function in a coordinated manner within the central nervous system.
- Published
- 2015
- Full Text
- View/download PDF
22. Bioinformatics Data Mining Approach Suggests Coexpression of AGTPBP1 with an ALS-linked Gene C9orf72.
- Author
-
Kitano S, Kino Y, Yamamoto Y, Takitani M, Miyoshi J, Ishida T, Saito Y, Arima K, and Satoh J
- Abstract
Background: Expanded GGGGCC hexanucleotide repeats located in the noncoding region of the chromosome 9 open reading frame 72 (C9orf72) gene represent the most common genetic abnormality for familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Formation of nuclear RNA foci, accumulation of repeat-associated non-ATG-translated dipeptide-repeat proteins, and haploinsufficiency of C9orf72 are proposed for pathological mechanisms of C9ALS/FTD. However, at present, the physiological function of C9orf72 remains largely unknown., Methods: By searching on a bioinformatics database named COXPRESdb composed of the comprehensive gene coexpression data, we studied potential C9orf72 interactors., Results: We identified the ATP/GTP binding protein 1 (AGTPBP1) gene alternatively named NNA1 encoding a cytosolic carboxypeptidase whose mutation is causative of the degeneration of Purkinje cells and motor neurons as the most significant gene coexpressed with C9orf72. We verified coexpression and interaction of AGTPBP1 and C9orf72 in transfected cells by immunoprecipitation and in neurons of the human brain by double-labeling immunohistochemistry. Furthermore, we found a positive correlation between AGTPBP1 and C9orf72 mRNA expression levels in the set of 21 human brains examined., Conclusions: These results suggest that AGTPBP1 serves as a C9orf72 interacting partner that plays a role in the regulation of neuronal function in a coordinated manner within the central nervous system.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.